ChoA Pharmaceutical Co., LTD. Logo

ChoA Pharmaceutical Co., LTD.

Global manufacturer of OTC medicines and health supplements distributed through pharmacies.

034940 | KO

Overview

Corporate Details

ISIN(s):
KR7034940007
LEI:
Country:
South Korea
Address:
서울특별시 영등포구 당산로2길 12 에이스테크노타워 101호(문래동3가, 에이스테크노타워1층), 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1988, ChoA Pharmaceutical Co., LTD. develops, manufactures, and supplies a range of pharmaceutical products and health foods. The company's portfolio includes approximately 200 products, specializing in over-the-counter (OTC) medicines, health supplements, digestives, and nutritional tonics. ChoA Pharmaceutical is recognized for its various product formulations, including tablets, capsules, liquids, and a significant line of drinkable ampoule products. The company focuses on pharmacies as its primary distribution channel and maintains a global business presence, exporting its products to various regions in Asia, the Middle East, and the Americas.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.2 MB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.0 MB
2025-03-24 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 22.3 KB
2025-03-14 00:00
Audit Report / Information
감사보고서제출
Korean 25.8 KB
2025-03-14 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 586.6 KB
2025-02-28 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 137.2 KB
2025-02-28 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 139.1 KB
2025-02-21 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 11.1 KB
2025-02-21 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.3 KB
2025-02-03 00:00
Regulatory News Service
생산재개(자율공시)
Korean 7.8 KB
2024-12-12 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-12-10 00:00
Regulatory News Service
생산중단
Korean 8.9 KB
2024-11-14 00:00
Quarterly Report
분기보고서 (2024.09)
Korean 934.8 KB
2024-08-14 00:00
Interim Report
반기보고서 (2024.06)
Korean 1.0 MB
2024-05-17 00:00
Related Party Transaction
계열회사변경(자율공시)
Korean 6.7 KB

Automate Your Workflow. Get a real-time feed of all ChoA Pharmaceutical Co., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ChoA Pharmaceutical Co., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ChoA Pharmaceutical Co., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden
ACTI
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing a novel GSK-3 inhibitor for hard-to-treat cancers.
United States of America
ACTU
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden
ACUC
Acurx Pharmaceuticals, Inc. Logo
Developing a new class of antibiotics to treat priority Gram-positive bacterial infections.
United States of America
ACXP
Adagene Inc. Logo
Develops novel antibody-based immunotherapies for cancer using an AI-driven discovery platform.
United States of America
ADAG
Adaptimmune Therapeutics PLC Logo
Develops novel T-cell therapies to treat solid tumors by engineering a patient's own immune cells.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops egg-based IgY antibodies as vaccine/antibiotic alternatives for animal and human health.
South Korea
179530
ADC Therapeutics SA Logo
Develops targeted antibody-drug conjugates for hematological and solid tumors.
United States of America
ADCT
ADIAL PHARMACEUTICALS, INC. Logo
Develops personalized, genetically-targeted drugs for treating Alcohol Use Disorder and addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Developing off-the-shelf gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET

Talk to a Data Expert

Have a question? We'll get back to you promptly.